Navigation Links
Biomatrica Announces the Appointment of Dr. James A. Robb as a Member of the Scientific Advisory Board
Date:5/26/2011

w technologies that deliver significant cost savings, superior logistics to cold handling and storage, without compromising biospecimen quality and integrity. All of these benefits are found in the technologies that have been and are being developed at Biomatrica, and I am delighted to serve on the company's Scientific Advisory Board."  

"Biomatrica is proud to have Dr. Robb join our SAB team bringing a wealth of experience, expertise and knowledge in clinical and molecular diagnostics for disease management and stratification," says Dr. Rolf Muller, Biomatrica's Chief Scientific Officer, President and Founder. "Dr. Robb will play a key role in helping Biomatrica chart a new course with new technologies under development designed for efficient management of critical biological samples for use in clinical trials, diagnostics, biobanking, genomics research, as well as forensic investigations. With Jim joining our SAB, we believe that Biomatrica is primed to become the leader in ambient stabilization for all biosamples and create the types of solutions that support and enhance better management of samples for advancing globalized health care and personalized medicine."

About Biomatrica, Inc.

Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing, shipping and assaying biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA and RNA with no sample degradation, thus labs can reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from p
'/>"/>

SOURCE Biomatrica
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biomatrica Launches New Partnership Program - Biomatrica Connect(TM)
2. Biomatrica Launches SampleWare 3.1
3. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
4. Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan
5. Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage
6. Sequenom Announces Participation at Jefferies 2011 Global Healthcare Conference
7. WaferGen Announces $30 Million Financing
8. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
9. Vermillion Announces Notice of Allowance for Alzheimer Patent
10. VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
11. Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Portage Biotech Inc. ("Portage" or "the Company" )) (OTC ... announce that the Company will be presenting  at the ... held in London, UK . Portage,s ... James Mellon , a director of Portage, will provide ... at its subsidiaries, Portage Pharmaceuticals Ltd. ("PPL"), and Biohaven ...
(Date:4/16/2015)... 2015 ChemRar High ... and R&D group, and Lancet, Russian Distribution ... and commercialization of new medicines in ... to stimulate the innovative development of the ... http://photos.prnewswire.com/prnh/20150416/739742-a) ,     (Logo: http://photos.prnewswire.com/prnh/20150416/739742-b) , ...
(Date:4/16/2015)... , April 16, 2015  Scientists from Cleave ... Drugs on the Horizon," at the American Association for ... PA on Sunday, April 19, 2015 from ... Cleave,s Director of Biology, will present new in vivo ... first-in-class, oral inhibitor of p97, a critical enzyme that ...
(Date:4/16/2015)... , Switzerland , ... Debiopharm International SA (Debiopharm), part of Debiopharm Group ™ , ... drugs that target unmet medical needs as ... preclinical data on the investigational compounds Debio 1143 ... will be presented at the 2015 Annual ...
Breaking Biology Technology:Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
... July 25, 2011 MiMedx Group, Inc.  (OTCBB: MDXG), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... six months ended June 30, 2011. The ... an 85% percent increase over first quarter of 2011 ...
... ERT (NASDAQ: ERT ) announced today that it ... Monday, August 1, after the market closes.  After the release, ... ET that day. For the conference call, ... States or 1-412-858-4600 when calling internationally. There will be a ...
... SHELTON, Conn., July 22, 2011 Modern Plastics, one ... stock shapes and medical-grade plastics, has moved from ... new address is 88 Long Hill Cross Road, Shelton, ... features an advanced environmentally controlled clean room for storage ...
Cached Biology Technology:MiMedx Group Announces Second Quarter 2011 Results 2MiMedx Group Announces Second Quarter 2011 Results 3MiMedx Group Announces Second Quarter 2011 Results 4MiMedx Group Announces Second Quarter 2011 Results 5MiMedx Group Announces Second Quarter 2011 Results 6MiMedx Group Announces Second Quarter 2011 Results 7MiMedx Group Announces Second Quarter 2011 Results 8MiMedx Group Announces Second Quarter 2011 Results 9MiMedx Group Announces Second Quarter 2011 Results 10ERT Reports Second Quarter 2011 Operating Results on August 1, 2011 2
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/143028 for MINIATURE, MULTI-PURPOSE ... TRANSFER  NXT-ID introduces a new revolutionary ... patent surrounds the use of miniature antenna modules ...
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/26/2015)... 26, 2015 The Granite Club, ... and athletic club, today announced it has implemented a ... of movement for members and staff, while restricting access ... process, we selected FST,s IMID Access system because it ... our members and staff, in addition to unparalleled security," ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... bioMETRX Inc., (OTC,Bulletin Board: BMRX), today announced ... agreement with EZ Print, LLC for the advanced ... purchase,agreement., EZ Print, LLC will invest considerable ... the enterprise document production,business. Currently the technology branded ...
... largest field trial of its kind in the United ... Miscanthus x giganteus outperforms current biofuels sources by ... production in the U.S. could significantly reduce the acreage ... the researchers report. The new findings, from researchers ...
... (CLIC), a group of researchers from 10 academic and ... by physicians at Case Western Reserve University School of ... grant from the National Institutes of Health (NIH) to ... deficiency that causes AIDS. The grant will fund four ...
Cached Biology News:bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC 2bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC 3Miscanthus can meet US biofuels goal using less land than corn or switchgrass 2Miscanthus can meet US biofuels goal using less land than corn or switchgrass 3Case Western Reserve University School of Medicine researchers receive $10.8 million 2
For removal of the zona pellucida. Sterile, Mouse Embryo tested...
Request Info...
Imject Freund's Complete Adjuvant (FCA)...
... the secretion of cytoplasmic granules, is ... response of leukocytes (e.g. basophils, neutrophils, ... to histamine, these secretory granules contain ... chemokines, and many proteases (Hallgren, 2001). ...
Biology Products: